18 Jan 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : inkoop eigen aandelen
|
40204020 Clothing and Accessories |
Other subject |
18 Jan 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : acquisition of treasury shares
|
40204020 Clothing and Accessories |
Other subject |
18 Jan 2024
17:52 CET |
LOTUS BAKERIES |
Disposal of treasury shares
|
45102020 Food Products |
Other subject |
18 Jan 2024
17:45 CET |
DMS IMAGING S.A. |
DMS Imaging : Chiffre d'affaires annuel 2023 : +15% à 40,5 M EUR .
|
20103010 Biotechnology |
Sales, Income |
18 Jan 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD® Announces Start of HemON NL Clinical Study
|
20101025 Health Services |
- |
18 Jan 2024
07:00 CET |
ARGENX SE |
argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
|
20103010 Biotechnology |
Other subject |
17 Jan 2024
22:05 CET |
NYXOAH SA |
Nyxoah Annonce ses Priorités Stratégiques pour 2024
|
20102010 Medical Equipment |
Other subject |
17 Jan 2024
22:05 CET |
NYXOAH SA |
Nyxoah Announces 2024 Strategic Priorities
|
20102010 Medical Equipment |
Other subject |
17 Jan 2024
19:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
|
20103010 Biotechnology |
- |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook
|
20103010 Biotechnology |
Corporate life |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024
|
20103010 Biotechnology |
Corporate life |
16 Jan 2024
19:30 CET |
HYLORIS |
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)
|
20103010 Biotechnology |
Products and services |
16 Jan 2024
19:30 CET |
HYLORIS |
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
|
20103010 Biotechnology |
Products and services |
16 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
16 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
16 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
16 Jan 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 08/01/2024 tot 12/01/2024
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Buy back of own shares – week from 08/01/2024 to 12/01/2024
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 08/01/2024 au 12/01/2024
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
08:00 CET |
KBC |
KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe
|
30101010 Banks |
Other subject |
16 Jan 2024
08:00 CET |
KBC |
KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen
|
30101010 Banks |
Other subject |
16 Jan 2024
08:00 CET |
KBC |
KBC Group: Update regarding the KBC Group share buyback programme
|
30101010 Banks |
Other subject |
16 Jan 2024
07:30 CET |
GIMV |
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
07:30 CET |
GIMV |
Gimv neemt als co-leadinvesteerder deel aan een Series C financieringsronde van 30 miljoen EUR bij Onera Health.
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
07:30 CET |
GIMV |
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2024
07:30 CET |
GIMV |
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
|
30202010 Asset Managers and Custodians |
Other subject |
15 Jan 2024
18:09 CET |
GBL |
GBL - Transacties op GBL-aandelen 15-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
15 Jan 2024
18:08 CET |
GBL |
GBL - Transactions sur actions propres 15-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
15 Jan 2024
18:08 CET |
GBL |
GBL - Transactions on GBL shares 15-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
15 Jan 2024
17:59 CET |
CENERGY |
Hellenic Cables remporte un contrat pour les parcs éoliens offshore de Bałtyk II et Bałtyk III
|
50202010 Electrical Components |
News contracts |
15 Jan 2024
17:58 CET |
CENERGY |
Hellenic Cables awarded a contract for Bałtyk II and Bałtyk III offshore wind farms
|
50202010 Electrical Components |
News contracts |
15 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Mise à jour concernant le programme de rachat d'actions propres (15 janvier 2024)
|
40301010 Entertainment |
Corporate life |
15 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Update inkoopprogramma eigen aandelen (15 januari 2024)
|
40301010 Entertainment |
Corporate life |
15 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Update share buyback program (15 January 2024)
|
40301010 Entertainment |
Corporate life |
15 Jan 2024
08:33 CET |
TITAN CEMENT |
Programme de rachats d'actions
|
50101030 Cement |
Other subject |
15 Jan 2024
08:32 CET |
TITAN CEMENT |
Share buyback programme
|
50101030 Cement |
Other subject |
15 Jan 2024
07:25 CET |
JENSEN-GROUP |
Inkoop eigen aandelen - wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
15 Jan 2024
07:24 CET |
JENSEN-GROUP |
Share buyback – weekly update
|
50204000 Machinery: Industrial |
Other subject |
15 Jan 2024
07:00 CET |
BIOSENIC |
BioSenic S.A. : Transparency notifications received from François Rieger
|
20103010 Biotechnology |
Other subject |
15 Jan 2024
07:00 CET |
BIOSENIC |
BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic troxide for cGvHD treatment
|
20103010 Biotechnology |
Alliances and agreements |
15 Jan 2024
07:00 CET |
BIOSENIC |
BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger
|
20103010 Biotechnology |
Other subject |
15 Jan 2024
07:00 CET |
BIOSENIC |
COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE
|
20103010 Biotechnology |
Alliances and agreements |
12 Jan 2024
18:00 CET |
ONTEX GROUP |
Transparency Declaration Notification
|
45201020 Personal Products |
Other subject |
12 Jan 2024
18:00 CET |
ONTEX GROUP |
Kennisgeving transparantieverklaring
|
45201020 Personal Products |
Other subject |